Interventional Cardiology, Division of Cardiology, University of Colorado Denver, Aurora, 80045, USA.
Cardiol Clin. 2013 Aug;31(3):401-15. doi: 10.1016/j.ccl.2013.05.002.
Patent foramen ovale (PFO) is a common developmental anomaly that allows for the passage of blood and other substances from the venous to the arterial circulation. The study of PFO closure has been challenging due to widely available off-label closures performed outside the clinical trial setting. To date, no study has demonstrated benefit of closure using intention-to-treat analyses. Secondary and subpopulation analyses suggest that there is benefit to closure in patients with atrial septal aneurysms and/or substantial degrees of right-to-left shunting. This article reviews the history, associated technologies, and current data regarding PFO closure.
卵圆孔未闭(PFO)是一种常见的发育异常,可使血液和其他物质从静脉循环流向动脉循环。由于在临床试验环境之外进行了广泛的、未经批准的闭合治疗,因此对 PFO 闭合的研究一直具有挑战性。迄今为止,没有研究通过意向治疗分析证明闭合的益处。次要和亚人群分析表明,对于房间隔瘤和/或大量右向左分流的患者,闭合是有益的。本文回顾了 PFO 闭合的历史、相关技术和现有数据。